Quick Answer– The valsartan lawsuit centers on NDMA contamination in blood pressure medication, with cases consolidated under MDL 2875 in the District of New Jersey.– Claimants who took contaminated valsartan and were later diagnosed with specific cancers may qualify for compensation, including those whose cases remain unresolved in 2026.– Payout estimates for individual personal injury […]
Quick Answer– The Boka toothpaste lawsuit centers on allegations that the company made scientifically unsubstantiated claims about nano-hydroxyapatite's ability to remineralize teeth and replace fluoride.– Consumers who purchased Boka toothpaste products, including the Ela Mint and Coco Ginger formulas, within the applicable statute of limitations period may qualify to join the class action.– No final […]
Quick Answer– What it is: Patients harmed by allegedly contaminated or substandard compounded medications from Empower Pharmacy are filing personal injury lawsuits and mass tort claims, citing FDA-documented sterile compounding failures.– Who qualifies: Individuals who received compounded drugs from Empower Pharmacy and suffered infections, vision loss, systemic injury, or other serious adverse events linked to […]